In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 6, 2009, Pages 1295-1297

  Badali, Hamid ^a,b,c   De Hoog, G Sybren ^a,b   Curfs Breuker, Ilse ^d   Andersen, Birgitte ^e   Meis, Jacques F ^d  

^a CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Alternaria alternata; Alternaria infectoria; Anidulafungin; In vitro susceptibility; Isavuconazole

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; ISAVUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; RIBOSOME DNA; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ALTERNARIA; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SEQUENCE ANALYSIS;

ALTERNARIA; ANTIFUNGAL AGENTS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 65749093275     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp109     Document Type: Letter

References (6)

1. Pastor FJ, Guarro J. Alternaria infections: Laboratory diagnosis and relevant clinical features. Clin Microbiol Infect 2008; 14: 734-46.
2. Hipolito E, Faria E, Alves AF et al. Alternaria infectoria brain abscess in a child with chronic granulomatous disease. Eur J Clin Microbiol Infect Dis 2008; doi:10.1007/s10096-008-0623-2.
3. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi - Second Edition: Approved Standard M38-A2. CLSI, Wayne, PA, USA, 2008.
4. Sabatelli F, Patel R, Mann PA et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006; 50: 2009-15.
5. Cuenca-Estrella M, Gomez-Lopez A, Mellado E et al. Head-to-head comparison of the activities of currently available antifungal agents against 3378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006; 50: 917-21.
6. González GM. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi. Med Mycol 2009; 47: 71-6.